Cary Street Partners Investment Advisory’s LianBio American Depositary Shares LIAN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$1.49K	–	1861
2023 Q3	$1.49K	Hold	1,000	–	–	﹤0.01%	1698
2023 Q2	$2.28K	Hold	1,000	–	–	﹤0.01%	1571
2023 Q1	$1.96K	Hold	1,000	–	–	﹤0.01%	1503
2022 Q4	$1.64K	Buy	+1,000	New	+$1.56K	﹤0.01%	1530

Other funds holding LIAN

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Cary Street Partners Investment Advisory's LIAN Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 1,000 shares — an estimated $1.49K sold.

Cary Street Partners Investment Advisory first reported a position in LIAN in Q4 2022 and held it in 4 quarters. The position peaked at $2.28K in Q2 2023. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

Cary Street Partners Investment Advisory reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 1,000 LianBio American Depositary Shares shares in Q4 2023, an estimated $1.49K.
Cary Street Partners Investment Advisory first reported a position in LianBio American Depositary Shares in Q4 2022 and held it in 4 quarters.
Cary Street Partners Investment Advisory's LianBio American Depositary Shares position peaked at $2.28K in Q2 2023.
29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.